Additionally, the PD-L1+ CAFs group had a higher number of CAFs in the tumor, indicating poor prognosis because we previously reported that the proportion of CAFs in the tumor was significantly correlated with the outcomes in clinical studies [11, 12]. The gene discussed is CD274; the disease is neoplasm.